Corient Private Wealth’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$179M Sell
1,197,426
-1,177,833
-50% -$191M 0.26% 78
2025
Q4
$444M Buy
2,375,259
+1,420,963
+149% +$338M 0.3% 70
2025
Q3
$267M Sell
954,296
-145,108
-13% -$37M 0.42% 45
2025
Q2
$240M Sell
1,099,404
-44,792
-4% -$7.23M 0.32% 56
2025
Q1
$160M Buy
1,144,196
+92,172
+9% +$15M 0.26% 84
2024
Q4
$173M Sell
1,052,024
-184,479
-15% -$32.8M 0.29% 75
2024
Q3
$211M Buy
1,236,503
+177,963
+17% +$25.8M 0.33% 59
2024
Q2
$149M Sell
1,058,540
-30,941
-3% -$3.84M 0.26% 83
2024
Q1
$137M Sell
1,089,481
-129,321
-11% -$14.8M 0.24% 95
2023
Q4
$128M Sell
1,218,802
-102,819
-8% -$11.2M 0.24% 98
2023
Q3
$140M Buy
1,321,621
+33,356
+3% +$3.86M 0.32% 69
2023
Q2
$153M Buy
1,288,265
+130,853
+11% +$13.5M 0.35% 64
2023
Q1
$108M Buy
1,157,412
+356,166
+44% +$31.2M 0.29% 87
2022
Q4
$65.5M Buy
+801,246
New +$60.9M 0.24% 109

Other funds holding ORCL

Corient Private Wealth's ORCL Position: Q1 2026 in Review

Corient Private Wealth reduced its Oracle (ORCL) stake by 50% in Q1 2026, selling an estimated $191M and leaving 1,197,426 shares worth $179M. The position accounts for 0.26% of the portfolio, ranked #78.

Corient Private Wealth first reported a position in ORCL in Q4 2022 and has held it in 14 quarters since. The position peaked at $444M in Q4 2025. 3,472 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Corient Private Wealth held 1,197,426 shares of Oracle worth $179M as of Q1 2026.
  • Corient Private Wealth sold 1,177,833 Oracle shares in Q1 2026, an estimated $191M.
  • Oracle made up 0.26% of Corient Private Wealth's portfolio in Q1 2026, its #78 holding.
  • Corient Private Wealth first reported a position in Oracle in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Oracle position peaked at $444M in Q4 2025.
  • 3,472 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.